These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 9630626)

  • 1. Inhibition of 14-kDa PLA2 by 2-acylamino-alkylphospholipids: the influence of amide acidity.
    Kley JT; Unger C; Massing U
    Biochim Biophys Acta; 1998 Jun; 1392(2-3):193-201. PubMed ID: 9630626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Competitive inhibition of lipolytic enzymes. VI. Inhibition of two human phospholipases A2 by acylamino phospholipid analogues.
    van den Berg L; Franken PA; Verheij HM; Dijkman R; de Haas GH
    Biochim Biophys Acta; 1992 Feb; 1124(1):66-70. PubMed ID: 1543727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Competitive inhibition of lipolytic enzymes. III. Some acylamino analogues of phospholipids are potent competitive inhibitors of porcine pancreatic phospholipase A2.
    de Haas GH; Dijkman R; van Oort MG; Verger R
    Biochim Biophys Acta; 1990 Mar; 1043(1):75-82. PubMed ID: 2310763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Competitive inhibition of lipolytic enzymes. VII. The interaction of pancreatic phospholipase A2 with micellar lipid/water interfaces of competitive inhibitors.
    Deveer AM; Franken PA; Dijkman R; Meeldijk J; Egmond MR; Verheij HM; Verger R; de Haas GH
    Biochim Biophys Acta; 1992 Apr; 1125(1):73-81. PubMed ID: 1567910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Competitive inhibition of lipolytic enzymes. IV. Structural details of acylamino phospholipid analogues important for the potent inhibitory effects on pancreatic phospholipase A2.
    de Haas GH; Dijkman R; Ransac S; Verger R
    Biochim Biophys Acta; 1990 Oct; 1046(3):249-57. PubMed ID: 2171669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Competitive inhibition of lipolytic enzymes. IX. A comparative study on the inhibition of pancreatic phospholipases A2 from different sources by (R)-2-acylamino phospholipid analogues.
    de Haas GH; Dijkman R; Lugtigheid RB; Dekker N; Van den Berg L; Egmond MR; Verheij HM
    Biochim Biophys Acta; 1993 Apr; 1167(3):281-8. PubMed ID: 8481389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Competitive inhibition of lipolytic enzymes. X. Further delineation of the active site of pancreatic phospholipases A2 from pig, ox and horse by comparing the inhibitory power of a number of (R)-2-acylamino phospholipid analogues.
    Dijkman R; Cox R; van den Berg L; Verheij HM; De Haas GH
    Biochim Biophys Acta; 1994 Apr; 1212(1):50-8. PubMed ID: 8155726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Competitive inhibition of lipolytic enzymes. V. A monolayer study using enantiomeric acylamino analogues of phospholipids as potent competitive inhibitors of porcine pancreatic phospholipase A2.
    Ransac S; Deveer AM; Rivière C; Slotboom AJ; Gancet C; Verger R; De Haas GH
    Biochim Biophys Acta; 1992 Jan; 1123(1):92-100. PubMed ID: 1730050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. X-ray crystal structure determination and molecular dynamics simulation of prophospholipase A2 inhibited by amide-type substrate analogues.
    Tomoo K; Yamane A; Ishida T; Fujii S; Ikeda K; Iwama S; Katsumura S; Sumiya S; Miyagawa H; Kitamura K
    Biochim Biophys Acta; 1997 Jul; 1340(2):178-86. PubMed ID: 9252105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. pH dependence of the reaction rate of p-bromophenacyl bromide and of the binding constants of Ca2+ and an amide-type substrate analog to bovine pancreatic phospholipase A2.
    Fujii S; Meida M; Tani T; Inoue S; Iwama S; Katsumura S; Ikeda K
    Arch Biochem Biophys; 1998 Jun; 354(1):73-82. PubMed ID: 9633600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical role of a hydrogen bond in the interaction of phospholipase A2 with transition-state and substrate analogues.
    Yu L; Dennis EA
    Proc Natl Acad Sci U S A; 1991 Oct; 88(20):9325-9. PubMed ID: 1924395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indole inhibitors of human nonpancreatic secretory phospholipase A2. 1. Indole-3-acetamides.
    Dillard RD; Bach NJ; Draheim SE; Berry DR; Carlson DG; Chirgadze NY; Clawson DK; Hartley LW; Johnson LM; Jones ND; McKinney ER; Mihelich ED; Olkowski JL; Schevitz RW; Smith AC; Snyder DW; Sommers CD; Wery JP
    J Med Chem; 1996 Dec; 39(26):5119-36. PubMed ID: 9005255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arbutin inhibits PLA2 in partially hydrated model systems.
    Oliver AE; Crowe LM; de Araujo PS; Fisk E; Crowe JH
    Biochim Biophys Acta; 1996 Jul; 1302(1):69-78. PubMed ID: 8695657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conformation of micellar phospholipid bound to the active site of phospholipase A2.
    Plesniak LA; Yu L; Dennis EA
    Biochemistry; 1995 Apr; 34(15):4943-51. PubMed ID: 7711016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indole inhibitors of human nonpancreatic secretory phospholipase A2. 2. Indole-3-acetamides with additional functionality.
    Dillard RD; Bach NJ; Draheim SE; Berry DR; Carlson DG; Chirgadze NY; Clawson DK; Hartley LW; Johnson LM; Jones ND; McKinney ER; Mihelich ED; Olkowski JL; Schevitz RW; Smith AC; Snyder DW; Sommers CD; Wery JP
    J Med Chem; 1996 Dec; 39(26):5137-58. PubMed ID: 8978843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New phospholipase A2 inhibitor: synthesis and inhibition mechanism of oxazolidinone phospholipid analog.
    Iwama S; Matsuda T; Katsumura S; Tani T; Fujii S; Ikeda K; Takehara H
    Bioorg Med Chem; 1995 Oct; 3(10):1397-403. PubMed ID: 8564407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The binding of amide substrate analogues to phospholipase A2. Studies by 13C-nuclear-magnetic-resonance and infrared spectroscopy.
    Slaich PK; Primrose WU; Robinson DH; Wharton CW; White AJ; Drabble K; Roberts GC
    Biochem J; 1992 Nov; 288 ( Pt 1)(Pt 1):167-73. PubMed ID: 1445261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbonothioate phospholipids as substrate for a spectrophotometric assay of phospholipase A2.
    Yu L; Ternansky RJ; Crisologo JF; Chang J; Baker BL; Coutts SM
    Anal Biochem; 1998 Dec; 265(1):35-41. PubMed ID: 9866705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SB 203347, an inhibitor of 14 kDa phospholipase A2, alters human neutrophil arachidonic acid release and metabolism and prolongs survival in murine endotoxin shock.
    Marshall LA; Hall RH; Winkler JD; Badger A; Bolognese B; Roshak A; Flamberg PL; Sung CM; Chabot-Fletcher M; Adams JL
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1254-62. PubMed ID: 7562496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence that 85 kDa phospholipase A2 is not linked to CoA-independent transacylase-mediated production of platelet-activating factor in human monocytes.
    Winkler JD; Bolognese BJ; Roshak AK; Sung CM; Marshall LA
    Biochim Biophys Acta; 1997 Jun; 1346(2):173-84. PubMed ID: 9219900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.